Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions
RSC Advances · 2025 · 15 (31) · 25560-25578
DOI: 10.1039/d5ra03731j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2025. Verfasst von Chengmei Ge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou 310000 Zhejiang China weimh@srrsh.com. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Peptide-based strategies, combined with smart delivery platforms and biomaterials, offer precise, stable, and targeted therapies for IBD, addressing key translational barriers.
Autor:innen und Institutionen
- Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou 310000 Zhejiang China weimh@srrsh.com.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou 310000 Zhejiang China mushougongx@zju.edu.cn.
ORCID-Profile: Meihao Wei
Zitieren
APA
Ge, C., Wang, Z., Wang, Y., & Wei, M. (2025). Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. RSC Advances, 15(31), 25560-25578. https://doi.org/10.1039/d5ra03731j
Vancouver
Ge C, Wang Z, Wang Y, Wei M. Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions. RSC Advances. 2025;15(31):25560-25578. doi:10.1039/d5ra03731j
BibTeX
@article{Ge2025,
author = {Ge, Chengmei and Wang, Zhen and Wang, Yu and Wei, Meihao},
title = {Peptide-based therapeutic and delivery strategies for inflammatory bowel disease: challenges and future directions},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {31},
pages = {25560--25578},
doi = {10.1039/d5ra03731j}
}
EUVIMED